{
  "num_tested_probands": [
    3,
    3,
    0
  ],
  "num_positive_het_probands": [
    0,
    1,
    0
  ],
  "positive_phenotypes": [
    [
      "SS",
      "AS"
    ],
    "prolonged duration of action of succinylcholine",
    []
  ],
  "num_compound_or_double_hets": [
    1,
    2,
    0
  ],
  "explanation": {
    "num_tested_probands": [
      "The number of individual probands for whom genetic testing was reported. This is stated in the first sentence of the article: 'Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia'.",
      "The proband in family 1 had the genotype BCHE*115D*I3E4-14C/BCHE*FS126, and another patient was heterozygous for BCHE*FS126.",
      "No probands were mentioned in the provided text."
    ],
    "num_positive_het_probands": [
      "The number of probands who were heterozygous for a pathogenic variant. This is stated in the results section: 'BCHE*I3E4-14C was in linkage with a known silent variant.' However, it is not explicitly stated that this individual is heterozygous for BCHE*I3E4-14C.",
      "One patient with a low BChE activity was genotyped as heterozygous for BCHE*FS126.",
      "No heterozygous probands were reported."
    ],
    "positive_phenotypes": [
      "Clinical phenotypes associated with the positive probands. This is stated in the results section: 'Table 1 Biochemical characteristics, phenotypes, and genotypes in families with novel mutations.' The phenotypes listed are SS (homozygous for silent variants) and AS (heterozygous for atypical and silent variants).",
      "The patients had prolonged duration of action of succinylcholine, and one patient experienced 3 hours of apnoea.",
      "No clinical phenotypes were associated with positive probands."
    ],
    "num_compound_or_double_hets": [
      "The number of individuals reported to have compound or double heterozygous mutations. This is stated in the results section: 'The proband in family 3 was compound heterozygous for BCHE*328D and BCHE*142M.'",
      "One patient with a low BChE activity was compound heterozygous for BCHE*328D and BCHE*142M.",
      "No compound or double heterozygotes were mentioned."
    ]
  }
}